Global Regenerative Medicines Market- Market Dynamics
There are several factors driving and restraining the global regenerative medicines market. Some of these are listed below.
Technological innovations in stem cell therapy and tissue engineering
Growing prevalence of bone and joint diseases
Growing need of orthopedic surgeries
Advancements in nanotechnology
Increased in innovation in stem cell therapy
Rules laid down by regulatory bodies
Ethical issues related to regenerative medicines
Cost of the treatment.
The market is segmented on the basis of technology, applications, and geography.
By technology, the market is divided into stem cell therapy, biomaterial, and tissue engineering.
By type of applications, the market is segmented into bone graft substitutes, osteoarticular diseases, central nervous system and cardiovascular.
By geography, the market is segmented into North America, Europe, Asia-Pacific, and Rest of the World.
North America and Europe account for more than three-fourths of the revenue in 2013. However, technological advancement and research emphasis are growing in the Asia-Pacific region, so this is going to be a potential market for regenerative medicines.
This Report Offers:
High-level analysis of the competitive landscape, which in turn includes mergers & acquisitions, collaborations, new product launches and new strategies which major players are following to keep pace with the market.
Market analysis for the regenerative medicine market, with region-specific assessments and competition analysis on the global and regional scale.
Market definition along with the identification of key drivers and restraints.
Identification of factors instrumental in changing the market scenario, rising prospective opportunities, and identification of key companies that can influence this market on a global and regional scale.
Identification and analysis of the macro and micro factors that affect the market on both global and regional scale.
A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information.
A wide-ranging knowledge and insights about the major players in this industry and the key strategies adopted by them to sustain and grow in the studied market.
Insights on the major countries/regions where this industry is blooming and to also identify the regions that are still untapped.
2. EXECUTIVE SUMMARY
3. MARKET OVERVIEW
3.1 Global Regenerative medicine market
3.2 Current and Future Trends
3.3 Products in the market
3.4 Market Size and Share estimation
3.5 Regenerative medicine Stakeholders
4. MARKET DYNAMICS
4.1 Market Drivers
4.1.1 Technological Innovations in Stem Cell Therapy and Tissue Engineering
4.1.2 Growing prevalence of bone and Joint Diseases
4.1.3 Growing need of Orthopaedic Surgeries Fuels the need of Global regenerative Medicine Market
4.1.4 Increasing people Awareness
4.2 Market Restraints
4.2.1 Regulatory Constraints
4.2.2 Ethical Issues
4.2.3 Cost of Treatment
4.3 Regenerative Medicine Goals and Strategies
4.3.1 Current Markets
4.3.2 Geographic Expansion
4.3.3 New Product Innovation
4.4 PorterFive Force Analysis
4.4.1 Bargaining power of suppliers
4.4.2 Bargaining power of buyers
4.4.3 Threat of new entrants
4.4.4 Threat of substitutes
4.4.5 Competitive rivalry
5. MARKET SEGMENTATION
5.2 Market Segmentation, By Type of Technology
5.2.1 Stem Cell Therapy
5.2.3 Tissue Engineering
5.3 Market Segmentation, By Type of Applications
5.3.1 Bone Graft Substitutes
5.3.2 Osteoarticular Diseases
5.3.5 Central nervous system
5.4 Market Segmentation, By Type of Geography
5.4.1 North America
5.4.4 Rest of the World
6. Competitive Landscape
6.1 New Product Launch
6.2 Market Share Analysis by Key Players
6.3 Mergers & Acquisitions
6.4 Market Share Analysis
7. Strategies of Potential Companies
7.1 Mesoblast Ltd.
7.2 Athersys Inc.
7.3 Neo Stem Inc.
7.4 StemCells Inc.
7.5 Neuralstem Inc.
8. Strategies of Top 3 Potential Companies
8.1 Cellular Dynamics International, Inc.
8.2 Athersys, Inc
8.3 Cytori Therapeutics, Inc.
9. Company Profiles
9.1 Anika Therapeutics, Inc.
9.2 Arthrex, Inc.
9.3 Baxter International, Inc.
9.4 CONMED Corporation
9.5 DePuy Synthes, Inc.
9.6 Medtronic, Inc.
9.7 Smith & Nephew PLC
9.8 Stryker Corporation
9.9 Zimmer Holdings, Inc.